Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Study suggests anxiety increases the risk of subsequent cognitive progression in non-dementia elderly

Researchers investigate the effects of anxiety on cognitive degeneration in non-dementia elderly.

14 Jul 2023

Superagers more likely to have greater movement speed than typical older adults

People in their eighties who can recall everyday events and life experiences as well as someone 20 to 30 years younger – known as superagers – are also more likely to have greater movement speed than typical older adults.

13 Jul 2023

AI tool accurately counts brain lesions on MRI scans within seconds

An artificial intelligence (AI) tool developed at The University of Texas Health Science Center at San Antonio accurately counts brain lesions on MRI scans within seconds.

13 Jul 2023

MemTrax continuous recognition test shows promise in early detection of Alzheimer's disease

A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 12, entitled, "Advancing screening for cognitive impairment: the memtrax continuous recognition test."

13 Jul 2023

New biomarker could track progression of Alzheimer's disease

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines.

13 Jul 2023

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

Currently, there is no cure for amyloidosis, a life-threatening disease that can be present throughout the body, including the heart, kidneys, liver and brain. The most common localized form of amyloidosis, which is seen significantly more often, is in the brain.

13 Jul 2023

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

This year's "Hartwig Piepenbrock-DZNE Prize", endowed with 60,000 euros, goes to the British neuroscientist Alison Goate, DPhil. The award recognizes her outstanding contributions to research into Alzheimer's disease and frontotemporal dementia.

13 Jul 2023

Overdosed gene on chromosome 21 accelerates aging in people with Down's syndrome

An overdosed gene on chromosome 21 causes people with Down's Syndrome to age faster than the general population.

12 Jul 2023

Social isolation linked to brain volume loss in older adults

Older people who have little social contact with others may be more likely to have loss of overall brain volume, and in areas of the brain affected by dementia, than people with more frequent social contact, according to a study published in the July 12, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.

12 Jul 2023

New AI-aided biosensor developed to detect neurodegenerative diseases

By combining multiple advanced technologies into a single system, EPFL researchers have made a significant step forward in diagnosing neurodegenerative diseases (NDDs) such as Parkinson's disease (PD) and Alzheimer's disease (AD).

12 Jul 2023

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

On July 6, 2023, the U.S. Food and Drug Administration granted full approval to lecanemab, marketed as Leqembi, for the treatment of Alzheimer's disease.

12 Jul 2023

£1.5 million funding boost awarded for revolutionary test to improve early detection of Alzheimer's

A significant NIHR grant will enable researchers at the universities of Bath and Bristol, in collaboration with Cumulus Neuroscience, to develop revolutionary technology to help expand early dementia diagnosis.

11 Jul 2023

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

A $40.5 million grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), will fund the Asian Cohort for Alzheimer's Disease (ACAD) study at Penn Medicine and 15 other academic research centers across the United States and Canada.

11 Jul 2023

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

The American Geriatrics Society (AGS) supports the recently announced decision from the Centers for Medicare and Medicaid Services (CMS) to require the collection of real-world information via a registry to study monoclonal antibodies directed against amyloid for the treatment of Alzheimer's disease.

11 Jul 2023

Whole genome sequencing shows promise for early diagnosis of genetic disorders in newborns, infants

A new national study, led by researchers at Tufts Medical Center in Boston, has found whole genome sequencing (WGS) to be nearly twice as effective as a targeted gene sequencing test at identifying abnormalities responsible for genetic disorders in newborns and infants.

11 Jul 2023

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

Now that the emergency phase of the COVID-19 pandemic has ended, scientists are looking at ways to surveil indoor environments in real time for viruses.

10 Jul 2023

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Research discusses the process of discovering anti-inflammatory and neuroprotective drugs from medicinal plants found in the Australian rainforest. It focuses on the pathways from the discovery of bioactive plants to the validation in an appropriate neuro-inflammatory mouse model, using some examples from their current research.

9 Jul 2023

Alzheimer's Disease News and Research

Further Reading

Study suggests anxiety increases the risk of subsequent cognitive progression in non-dementia elderly

Superagers more likely to have greater movement speed than typical older adults

AI tool accurately counts brain lesions on MRI scans within seconds

MemTrax continuous recognition test shows promise in early detection of Alzheimer's disease

New biomarker could track progression of Alzheimer's disease

Monumental $11.5 million gift will enable FAU to find a cure for amyloidosis

British neuroscientist wins Hartwig Piepenbrock-DZNE Prize for contributions to dementia research

Overdosed gene on chromosome 21 accelerates aging in people with Down's syndrome

Social isolation linked to brain volume loss in older adults

New AI-aided biosensor developed to detect neurodegenerative diseases

Lecanemab: First disease-modifying therapy for Alzheimer's disease approved by FDA

£1.5 million funding boost awarded for revolutionary test to improve early detection of Alzheimer's

$40.5 million NIA grant to fund study of Alzheimer's disease in Asian Americans and Asian Canadians

AGS supports CMS decision to require registry data for monoclonal antibodies for Alzheimer's disease

Whole genome sequencing shows promise for early diagnosis of genetic disorders in newborns, infants

Real-time monitor can detect SARS-CoV-2 in indoor air within 5 minutes

Australian rainforest remedies: Scientists explore bioactive plant compounds as potential anti-neuroinflammatory agents

Quantum medicine: the way forward?

Why the next big hope for Alzheimer’s might not help most Black patients

Short sleep can diminish the cognitive benefits of physical activity

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News